A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations

Junfeng Wang,Xavier Pouwels,Bram Ramaekers,Geert Frederix,Chris van Lieshout,Rudolf Hoogenveen,Xinyu Li,G. Ardine de Wit,Manuela Joore,Hendrik Koffijberg,Anoukh van Giessen,Saskia Knies,Talitha Feenstra,the Dutch multi-use disease modeling consortium
DOI: https://doi.org/10.1007/s40273-024-01376-w
2024-04-14
PharmacoEconomics
Abstract:The current use of health economic decision models in HTA is mostly confined to single use cases, which may be inefficient and result in little consistency over different treatment comparisons, and consequently inconsistent health policy decisions, for the same disorder. Multi-use disease models (MUDMs) (other terms: generic models, whole disease models, disease models) may offer a solution. However, much is uncertain about their definition and application. The current research aimed to develop a blueprint for the application of MUDMs.
pharmacology & pharmacy,health care sciences & services,health policy & services,economics
What problem does this paper attempt to address?